A detailed history of Intrust Bank Na transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Intrust Bank Na holds 26,280 shares of GILD stock, worth $1.78 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
26,280
Previous 25,465 3.2%
Holding current value
$1.78 Million
Previous $2.06 Million 6.64%
% of portfolio
0.21%
Previous 0.24%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$71.58 - $87.29 $58,337 - $71,141
815 Added 3.2%
26,280 $1.93 Million
Q4 2023

Feb 05, 2024

BUY
$73.27 - $83.09 $156,284 - $177,230
2,133 Added 9.14%
25,465 $2.06 Million
Q3 2023

Nov 13, 2023

SELL
$73.94 - $80.67 $94,347 - $102,934
-1,276 Reduced 5.19%
23,332 $1.75 Million
Q2 2023

Aug 10, 2023

SELL
$76.01 - $86.7 $169,654 - $193,514
-2,232 Reduced 8.32%
24,608 $1.9 Million
Q1 2023

May 04, 2023

SELL
$77.31 - $88.08 $121,995 - $138,990
-1,578 Reduced 5.55%
26,840 $2.23 Million
Q4 2022

Feb 10, 2023

SELL
$62.32 - $89.47 $72,228 - $103,695
-1,159 Reduced 3.92%
28,418 $2.44 Million
Q3 2022

Nov 09, 2022

BUY
$59.54 - $68.01 $170,105 - $194,304
2,857 Added 10.69%
29,577 $1.83 Million
Q2 2022

Aug 16, 2022

BUY
$57.72 - $65.01 $218,123 - $245,672
3,779 Added 16.47%
26,720 $1.65 Million
Q1 2022

May 10, 2022

BUY
$57.92 - $72.58 $44,366 - $55,596
766 Added 3.45%
22,941 $1.36 Million
Q4 2021

Feb 03, 2022

BUY
$64.88 - $73.64 $15,441 - $17,526
238 Added 1.08%
22,175 $1.61 Million
Q3 2021

Nov 04, 2021

BUY
$67.69 - $73.03 $154,807 - $167,019
2,287 Added 11.64%
21,937 $1.53 Million
Q2 2021

Aug 05, 2021

BUY
$63.47 - $69.35 $140,522 - $153,540
2,214 Added 12.7%
19,650 $1.35 Million
Q1 2021

Jun 02, 2021

BUY
$60.0 - $68.46 $4,200 - $4,792
70 Added 0.4%
17,436 $1.13 Million
Q4 2020

Feb 10, 2021

SELL
$56.65 - $64.55 $261,213 - $297,640
-4,611 Reduced 20.98%
17,366 $1.01 Million
Q3 2020

Nov 05, 2020

SELL
$62.1 - $78.08 $235,793 - $296,469
-3,797 Reduced 14.73%
21,977 $1.39 Million
Q2 2020

Aug 05, 2020

SELL
$72.34 - $84.0 $246,317 - $286,020
-3,405 Reduced 11.67%
25,774 $1.98 Million
Q1 2020

May 06, 2020

BUY
$62.63 - $80.22 $591,602 - $757,758
9,446 Added 47.87%
29,179 $2.18 Million
Q4 2019

Feb 07, 2020

SELL
$61.62 - $67.78 $81,954 - $90,147
-1,330 Reduced 6.31%
19,733 $1.28 Million
Q3 2019

Nov 12, 2019

BUY
$62.51 - $69.0 $86,513 - $95,496
1,384 Added 7.03%
21,063 $1.34 Million
Q2 2019

Aug 12, 2019

BUY
$61.87 - $69.38 $233,868 - $262,256
3,780 Added 23.78%
19,679 $1.33 Million
Q1 2019

May 10, 2019

BUY
$62.53 - $70.05 $3,063 - $3,432
49 Added 0.31%
15,899 $1.03 Million
Q4 2018

Feb 06, 2019

SELL
$60.54 - $79.0 $247,124 - $322,478
-4,082 Reduced 20.48%
15,850 $992,000
Q3 2018

Nov 09, 2018

SELL
$71.28 - $78.92 $28,155 - $31,173
-395 Reduced 1.94%
19,932 $1.54 Million
Q2 2018

Aug 08, 2018

BUY
$64.88 - $75.68 $119,963 - $139,932
1,849 Added 10.01%
20,327 $1.44 Million
Q1 2018

May 03, 2018

BUY
$72.84 - $88.8 $63,735 - $77,700
875 Added 4.97%
18,478 $1.39 Million
Q4 2017

Feb 08, 2018

BUY
$71.15 - $83.52 $15,724 - $18,457
221 Added 1.27%
17,603 $1.26 Million
Q3 2017

Nov 06, 2017

BUY
$72.11 - $85.47 $1.25 Million - $1.49 Million
17,382
17,382 $1.41 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $84.7B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Intrust Bank Na Portfolio

Follow Intrust Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.